Glimepiride 1mg + Metformin Hydrochloride 500mg (SR) + Voglibose 0.2mg Tablets

Glimepiride 1mg + Metformin Hydrochloride 500mg (SR) + Voglibose 0.2mg Tablets Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

• Glimepiride 1mg + Metformin Hydrochloride 500mg (SR) + Voglibose 0.2mg Tablets

 QUALITATIVE AND QUANTITATIVE COMPOSITION:

• Glimepiride 1mg + Metformin Hydrochloride 500mg (SR) + Voglibose 0.2mg Tablets
  Each uncoated Bilayered tablet contains:
  Glimepiride IP…………………………………..1mg
  Metformin Hydrochloride IP…………….500mg
  (As Sustained Release Form)
  Voglibose IP………………………………………0.2mg
  Excipients………………………………………q.s
  Colour: Lake Quinoline Yellow

THERAPEUTIC INDICATIONS:

GLIMEPIRIDE+METFORMIN+VOGLIBOSE is a combination of anti-diabetic drugs used to treat type 2 diabetes mellites. Type 2 diabetes is a chronic or lifelong condition that affects the way your body processes glucose.

CAUTION & SCHEDULE:

CAUTION:  Read enclosed leaflet before use.
Keep medicine out of reach of children.
Tablet to be swallowed as a whole, and not to be chewed or crushed.

CAUTION: It is dangerous to take the prescription except under medical supervision.

SCHEDULE H PRESCRIPTION DRUG-WARNING: To be sold by retail on the prescription of a registered medical practitioner only. 

STORAGE & DOSAGE:

Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.

Dosage: As directed by the Physician.

Introduction to Glimepiride 2mg + Metformin Hydrochloride 1000mg (SR) + Voglibose 0.3mg Tablets

Glimepiride + Metformin SR + Voglibose Tablets combine three powerful antidiabetic medicines:

• Glimepiride (2mg) – increases insulin secretion

• Metformin Hydrochloride (1000mg SR) – reduces hepatic glucose output and improves insulin sensitivity

• Voglibose (0.3mg) – slows carbohydrate absorption and reduces postprandial blood glucose spikes

This triple-combination therapy offers comprehensive glycemic control for patients with Type 2 diabetes who are inadequately controlled on monotherapy or dual therapy.

Global Demand & Market Scope

The global diabetic therapeutics market is expanding at over 8% CAGR, with developing regions such as Africa, Southeast Asia, Latin America, and CIS countries increasingly importing advanced oral antidiabetic formulations. The combination of Glimepiride + Metformin + Voglibose is especially preferred for:

• Optimized glycemic control

• Lower cardiovascular risk

• Reduced glucose variability

• Improved adherence (single tablet convenience)

Taj Pharma meets this global demand by providing high-quality antidiabetic formulations compliant with international export regulations.

  In-Depth Details for Importers / Exporters / Global Buyers

As one of India’s most organized pharmaceutical exporters, Taj Pharma offers full support to global buyers sourcing Glimepiride 2mg + Metformin Hydrochloride 1000mg (SR) + Voglibose 0.3mg Tablets.

  Regulatory Documentation Provided

All required regulatory dossiers and documentation are provided:

• WHO-GMP Certificate

• COPP (Certificate of Pharmaceutical Product)

• Product Registration Dossier – CTD format

• BE/BA Studies (if required)

• Free Sale Certificate (FSC)

• Manufacturing License

• COA, MSDS, Stability Data

• Batch Manufacturing Records (BMR)

• Batch Packaging Records (BPR)

Taj Pharma ensures end-to-end support for markets across Asia, Africa, CIS, MENA, LATAM, and Europe (semi-regulated).

 Custom Packaging & Private Labeling

Taj Pharma offers complete customization for international buyers:

• Custom foil printed branding and packaging

• Mono-carton and box artwork support

• Multilingual labeling (English, Arabic, French, Spanish, Russian, Swahili, Portuguese)

• Blister pack customization (Alu-Alu / Alu-PVC)

• Bulk tablets available for repacking

This flexibility makes Taj Pharma a preferred contract manufacturer and private-label supplier across continents.

 Shelf-Life, Storage & Dosage Form

  Export Certifications Available

Taj Pharma holds the highest-quality certifications, including:

• WHO-GMP

• ISO 9001:2015

• ISO 14001

• GLP-certified facility

• FDA-approved plant (Indian FDA)

• EU-standard compliance manufacturing

• Global regulatory support

Such certifications allow buyers seamless registration in their respective markets.

 Target Export Countries & Global Markets

Taj Pharma exports Glimepiride + Metformin SR + Voglibose Tablets to:

Top 20 Export Countries:

Nigeria | Kenya | Ghana | Tanzania | Uganda | Myanmar | Vietnam | Philippines | Yemen | Afghanistan | Iraq | Iran | Peru | Bolivia | Chile | Mexico | Dominican Republic | Nepal | Cambodia |Ethiopia

Taj Pharma is continuously expanding into Europe, LATAM, and Central Asia with competitive pricing and regulatory support.

 Why Taj Pharma is the Most Trusted Manufacturer, Supplier & Exporter

Taj Pharma is among the top Indian firms producing high-quality antidiabetic medicines that meet stringent international standards. Here’s why global buyers prefer Taj Pharma:

  State-of-the-Art WHO-GMP Manufacturing Facility

• Located in Vapi, Gujarat

• Automated production lines

• Separate controlled zones

• HEPA filtration and HVAC-controlled areas

• In-house microbiology and analytical labs

• World-class cleanroom standards

These ensure contaminants, cross-contamination, or any form of risk is eliminated.

 Affordable Pricing with High Purity Standards

Taj Pharma delivers:

• Cost-effective pricing for distributors

• High drug purity

• Assured batch-to-batch consistency

• WHO-compliant quality control

With global inflation and rising healthcare costs, Taj Pharma remains a preferred cost-efficient exporter.

 Global Distribution & Supply Chain Strength

• Export to 40+ countries

• Partnerships with ministry buyers, NGOs & government tenders

• Robust cold-chain free transportation system

• Ready stocks for urgent orders

• Dedicated export team support

  Patient and Physician Trust

Side effects like hypoglycemia, abdominal pain, nausea, constipation are well-documented globally. Taj Pharma ensures patient awareness with clear labeling and medical safety norms:

• “Take with food to avoid GI upset”

• “Carry a sugar source for hypoglycemia”

• “Monitor blood glucose regularly”

This medical transparency boosts international confidence.

 Technical Product Specification Table

 Call to Action 

If you are an importer, distributor, or pharmaceutical procurement agency searching for the best manufacturer and supplier of Glimepiride 2mg + Metformin Hydrochloride 1000mg (SR) + Voglibose 0.3mg Tablets in India, Taj Pharma is your trusted partner.

📞 Contact Taj Pharma Export Team:
Email:  info@tajpharma.com
Exports Office: Vapi, Gujarat – India
Website: www.tajpharma.com

Get competitive pricing, complete regulatory support, and fast global delivery.

 Top 20 FAQs  

1. What is this triple combination tablet used for?

It is used for managing Type 2 Diabetes Mellitus by improving insulin sensitivity, secretion, and reducing glucose absorption.

2. Who manufactures it in India?

Taj Pharma is the leading manufacturer and exporter.

3. Is Taj Pharma WHO-GMP certified?

Yes, Taj Pharma holds WHO-GMP, ISO, COPP, and other major certifications.

4. Can it be taken on an empty stomach?

No, it must be taken with food to prevent hypoglycemia or stomach upset.

5. What are the common side effects?

Hypoglycemia, nausea, abdominal discomfort, flatulence, constipation.

6. Do you offer private labeling?

Yes, Taj Pharma provides full private-label and contract manufacturing services.

7. Is the product suitable for government tenders?

Yes, Taj Pharma regularly supplies to NGOs and ministry tenders.

8. What is the shelf life?

24–36 months depending on market requirements.

9. Can Taj Pharma support product registration?

Yes, complete CTD dossiers are provided.

10. What packaging options are available?

Alu-Alu, Alu-PVC, custom printed foils.

11. Are bulk tablets available?

Yes, large buyers can order bulk for repacking.

12. Does Taj Pharma ship worldwide?

Yes, the company exports to 40+ countries.

13. How long does dispatch take?

Ready stock: 7–10 days.
Fresh batch: 30–45 days.

14. Is stability data available?

Yes, both accelerated and real-time data.

15. What is the minimum order quantity?

MOQ begins at 100,000 tablets.

16. Can it be combined with insulin?

Only under physician supervision.

17. Does the SR formulation improve adherence?

Yes, it offers sustained release and better glycemic control.

18. What countries import this product?

Africa, Asia, MENA, CIS, LATAM.

19. Is the raw material quality certified?

All APIs are sourced from GMP/DMF approved manufacturers.

20. Why choose Taj Pharma?

Quality, documentation, pricing, global reach, and WHO-GMP compliance.